Erika Resetkova, M.D., PhD.

Peer-Reviewed Articles

1. Delgado Casanova LB, Dhamne S, Resetkova E, Guirguis MS, Puvvala A, Bevers TB, Bedrosian I, Huo L, Wanis KN. Risk of malignancy after diagnosis of radial sclerosing lesion without atypia. Breast Cancer Res Treat 217(2), 2026. e-Pub 2026. PMID: 42257745.
2. Fracol, ME, Miranda, R, Tsao, A, Rodriguez, MM, Nastoupil, L, Young, PA, Sherrod, AE, LeBlanc, DM, Hunsicker, L, Bacchi, CE, Gabriel, T, Myckatyn, TM, Tanaka, S, Kuykendall, LV, Resetkova, E, Evans, MG, Jagasia, P, McCarthy, CM, Santanelli di Pompeo, F, Hunt, KK, Medeiros, LJ, Haymaker, CL, Clemens, MW. Breast Implant–Associated Malignancies. Plastic and Reconstructive Surgery 157(5):774e-784e, 2026. e-Pub 2026. PMID: 42054062.
3. Ye, Q, Law, T, Klippel, D, Albarracin, C, Chen, H, Contreras, A, Ding, Q, Huo, L, Khazai, L, Middleton, LP, Resetkova, E, Sahin, AA, Sun, H, Sweeney, K, Symmans, WF, Wu, Y, Yoon, EC, Krishnamurthy, S. Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer. Modern Pathology 38(4), 2025. e-Pub 2025. PMID: 39788205.
4. Wanis KN, Goetz L, So A, Glencer AC, Sun SX, Teshome M, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol 31(11):7339-7346, 2024. e-Pub 2024. PMID: 39048903.
5. Olayinka O, Cox SE, Nasrazadani A, Resetkova E, Ivan D, Middleton LP. Invasive Carcinoma With Skin Adnexal Trichilemmal Hair Follicular Differentiation Occurring in the Breast: A Case Report With Detailed Immunohistochemical and Molecular Analysis. Int J Surg Pathol 32(4):10668969231189166, 2024. e-Pub 2023. PMID: 37525555.
6. Marques-Piubelli ML, Lyapichev KA, Fnu A, Adrada B, Stewart J, Hunt KK, Clemens MW, Iyer S, Wu Y, El Hussein S, Xu J, Ok CY, Li S, Pierson DM, Ferrufino-Schmidt MC, Nahmod KA, Yoga A, Hunsicker L, Evans MG, Resetkova E, Qiu L, Khanlari M, Garces SA, Bueso-Ramos CE, Medeiros LJ, Miranda RN. The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol 48(6):e43-e64, 2024. e-Pub 2024. PMID: 38451836.
7. Wang J, Peng Y, Sun H, Aung PP, Resetkova E, Yam C, Sahin AA, Huo L, Ding Q. TRPS1 and GATA 3 expression in invasive breast carcinoma with apocrine differentiation. Arch Pathol Lab Med 148(2):200-205, 2024. e-Pub 2023. PMID: 37074839.
8. Wang J, Chen H, Koenig J, Wu Y, Bedrosian I, Arun B, Ding Q, Khazai L, Resetkova E, Huo L, Sneige N, Albarracin C. Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers. Breast Cancer Res Treat 203(1):73-83, 2024. e-Pub 2023. PMID: 37751078.
9. Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Liu H, Zhang J, Resetkova E, Wang WL, Ding Q, Huo L, Yoon E. Unusual Staining of Immunohistochemical Markers PAX8 and CDX2 in Breast Carcinoma: A Potential Diagnostic Pitfall. Hum Pathol 125:35-47, 2022. e-Pub 2022. PMID: 35417734.
10. Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krisnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol 125:97-107, 2022. e-Pub 2022. PMID: 35413381.
11. Zhou P, Chang N, Abraham SC, Albarracin CT, Huo L, Chen H, Ding Q, Resetkova E, Middleton LP, Sahin AA, Bu H, Wu Y. Metastatic non-Hematopoietic Neoplasms to the Breast: A Study of 238 Cases. Hum Pathol 125:59-67, 2022. e-Pub 2022. PMID: 35447141.
12. Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
13. Van Bockstal MR, François A, Altinay S, Arnould L, Balkenhol M, Broeckx G, Burguès O, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Hastir D, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchiò C, Martin Martinez MD, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban A, Sinke R, Stanciu-Pop CM, van Deurzen CHM, Van de Vijver KK, Van Rompuy AS, Vincent-Salomon A, Wen HY, Wong S, Bouzin C, Galant C. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study. Mod Pathol 34(12):2130-2140, 2021. e-Pub 2021. PMID: 34218258.
14. Huang X, Ding Q, Guo H, Gong Y, Zhao J, Zhao M, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Hum Pathol 108:42-50, 2021. e-Pub 2021. PMID: 33221342.
15. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res 22(1):69, 2020. e-Pub 2020. PMID: 32576238.
16. Boros M, Resetkova E, Molnar C, Podoleanu C, Dema A, Olinca M, Alvarado-Cabrero I, Buiga R, Stolnicu S. Analysis of Clinical-Pathological Data with Impact on Overall Survival in Male Breast Carcinoma: An International Multi-Institutional Study of 217 Cases. Chirurgia (Bucur) 115(3):323-333, 2020. e-Pub 2020. PMID: 32614287.
17. Dano H, Altinay S, Arnould L, Bletard N, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchió C, Martinez DM, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban AM, Sinke R, Stanciu-Pop CM, Stobbe C, van Deurzen CHM, Van de Vijver K, Van Rompuy AS, Verschuere S, Vincent-Salomon A, Wen H, Bouzin C, Galant C, Van Bockstal MR. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study. Mod Pathol 33(3):354-366, 2020. e-Pub 2020. PMID: 31534203.
18. Wang S, Oh DY, Leventaki V, Drakos E, Zhang R, Sahin AA, Resetkova E, Edgerton ME, Wu W, Claret FX. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Cancer Lett 465:12-23, 2019. e-Pub 2019. PMID: 31473252.
19. Moseley TW, Shah SS, Nguyen CV, Rosenblat J, Resetkova E, Sneige N, Brandt KR, Huo L. Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions. Ann Surg Oncol. e-Pub 2019. PMID: 31187364.
20. Stolnicu S, Moncea D, Dema A, Geambasu S, Moldovan C, Comanescu M, Voidazan S, Georgescu R, Alvarado-Cabrero I, Resetkova E, Buiga R. Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target. Appl Immunohistochem Mol Morphol 25(2):e18-e20, 2017. e-Pub 2017. PMID: 28177976.
21. Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic Correlation of Residual Mammographic Microcalcifications After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer. Ann Surg Oncol 22(4):1111-7, 2015. e-Pub 2015. PMID: 25287438.
22. Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. e-Pub 2015. PMID: 25564996.
23. Schuh F, Biazús JV, Resetkova E, Benfica CZ, Ventura Ade F, Uchoa D, Graudenz M, Edelweiss MI. Histopathological grading of breast ductal carcinoma In Situ: validation of a web-based survey through intra-observer reproducibility analysis. Diagn Pathol 10:93, 2015. e-Pub 2015. PMID: 26159429.
24. Burch-Smith R, Tannir NM, Resetkova E, Tamboli P, Rao P. Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow up. Chin J Cancer. e-Pub 2014. PMID: 24589208.
25. Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology 62(2):267-74, 2013. e-Pub 2013. PMID: 22963676.
26. Resetkova E. A Pictorial Journey Through Variants of Ductal Carcinoma in Situ (DCIS) and DCIS Mimickers. Clin Breast Cancer 12(5):347-63, 2012. e-Pub 2012. PMID: 23040003.
27. Marian C, Boila A, Soanca D, Malau M, Podeanu DM, Resetkova E, Stolnicu S. Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature. APMIS. e-Pub 2012. PMID: 23030630.
28. Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT. Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 36(9):1353-8, 2012. e-Pub 2012. PMID: 22895267.
29. Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169-77, 2011. e-Pub 2011. PMID: 21334720.
30. Lee YS, Mathew J, Dogan BE, Resetkova E, Huo L, Yang WT. Imaging Features of Micropapillary DCIS: Correlation with Clinical and Histopathological Findings. Acad Radiol 18(7):797-803, 2011. e-Pub 2011. PMID: 21419669.
31. Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 59(1):106-15, 2011. e-Pub 2011. PMID: 21668471.
32. Resetkova E, Edelweiss M, Albarracin CT, Yang WT. Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution. Breast Cancer Res Treat 127(2):335-43, 2011. e-Pub 2011. PMID: 18626769.
33. Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J 16(6):573-80, 2010. e-Pub 2010. PMID: 21070433.
34. Schuh F, Biazús JV, Resetkova E, Benfica CZ, Edelweiss MI. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey. Pathol Res Pract 206(10):705-11, 2010. e-Pub 2010. PMID: 20663616.
35. Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 123(1):97-108, 2010. e-Pub 2010. PMID: 19911270.
36. Mehta R, Jain RK, Sneige N, Badve S, Resetkova E. Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast. J Clin Pathol 63(8):744-7, 2010. e-Pub 2010. PMID: 20702478.
37. Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT. Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data. J Nucl Med 50(2):231-238, 2009. e-Pub 2009. PMID: 19164229.
38. Cao Y, Li Y, Edelweiss M, Arun B, Rosen D, Resetkova E, Wu Y, Liu J, Sahin A, Albarracin CT. Loss of Annexin A1 Expression in Breast Cancer Progression. Appl Immunohistochem Mol Morphol 16(6):530-4, 2008. e-Pub 2008. PMID: 18776816.
39. Dawood S, Resetkova E, Gonzalez-Angulo AM. Trastuzumab administration associated with change in HER2 status. Clin Breast Cancer 8(4):366-9, 2008. e-Pub 2008. PMID: 18757266.
40. Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia. (PASH) tumors: A clinicopathologic study of 26 cases. Mod Path 21(2):201-207, 2008. e-Pub 2008.
41. Gokhale S, Rosen D, Sneige N, Diaz LK, Resetkova E, Sahin A, Liu J, Albarracin CT. Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol 15(4):451-455, 2007. e-Pub 2007. PMID: 18091390.
42. Edelweiss M, Gupta N, Resetkova E. Preoperative diagnosis of clear cell "sugar" tumor of the lung by computed tomography-guided fine-needle biopsy and core-needle biopsy. Ann Diagn Pathol 11(6):421-6, 2007. e-Pub 2007. PMID: 18022127.
43. May SA, Deavers MT, Resetkova E, Johnson D, Albarracin CT. Giant cell tumor of soft tissue arising in breast. Ann Diagn Pathol 11(5):345-9, 2007. e-Pub 2007. PMID: 17870021.
44. Bahrami A, Resetkova E, Ro JY, Ibañez JD, Ayala AG. Primary osteosarcoma of the breast: report of 2 cases. Arch Pathol Lab Med 131(5):792-795, 2007. e-Pub 2007. PMID: 17488168.
45. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: Association with poor outcome. Cancer 109(4):658-667, 2007. e-Pub 2007. PMID: 17211865.
46. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107(8):1760-8, 2006. e-Pub 2006. PMID: 16977650.
47. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12(15):4598-604, 2006. e-Pub 2006. PMID: 16899607.
48. Anderson P, Albarracin CT, Resetkova E. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med 130(4):e50-52, 2006. e-Pub 2006. PMID: 16594759.
49. Resetkova E, Albarracin C, Sneige N. Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature. Am J Surg Pathol 30(1):20-27, 2006. e-Pub 2006. PMID: 16330938.
50. Resetkova E, Padula A, Albarraccin CT, Sneige N. Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma. Arch Pathol Lab Med 129(3):e79-80, 2005. e-Pub 2005. PMID: 15737055.
51. Assad L, Resetkova E, Oliveira VL, Sun W, Stewart JM, Katz RL, Caraway NP. Cytologic features of renal medullary carcinoma. Cancer 105(1):28-34, 2005. e-Pub 2005. PMID: 15593260.
52. Padula A, Chin NW, Azeez S, Resetkova E, Andriko JA, Miettinen M. Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient. Ann Diagn Pathol 9(1):49-53, 2005. e-Pub 2005. PMID: 15692952.
53. Resetkova E, Gonzalez-Angulo AM, Sneige N, Mcdonnell TJ, Buzdar AU, Kau SW, Yamamura Y, Reuben JM, Hortobagyi GN, Cristofanilli M. Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma. Cancer 101(5):913-917, 2004. e-Pub 2004. PMID: 15329897.
54. Resetkova E, Sahin A, Ayala AG, Sneige N. Breast carcinoma with choriocarcinomatous features. Ann Diagn Pathol 8(2):74-79, 2004. e-Pub 2004. PMID: 15060884.
55. Yao DX, Hoda SA, Yin DY, Kuhel WI, Harigopal M, Resetkova E, DeLellis RA. Interpretative problems and preparative technique influence reliability of intraoperative parathyroid touch imprints. Arch Pathol Lab Med 127(1):64-67, 2003. e-Pub 2003. PMID: 12521369.
56. Resetkova E, Flanders DJ, Rosen PP. Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation. Arch Pathol Lab Med 127(1):77-80, 2003. e-Pub 2003. PMID: 12521372.
57. Resetkova E, Hoda SA, Clarke JL, Rosen PP. Benign heterotopic epithelial inclusions in axillary lymph nodes. Histological and immunohistochemical patterns. Arch Pathol Lab Med 127(1):e25-7, 2003. e-Pub 2003. PMID: 12562290.
58. Resetkova E, Hoda SA. "Ossifying-type" mammary calcifications. Arch Pathol Lab Med 126(8):995-996, 2002. e-Pub 2002. PMID: 12197511.
59. Hoda SA, Resetkova E, Yusuf Y, Cahan A, Rosen PP. Megakaryocytes mimicking metastatic breast carcinoma. Arch Pathol Lab Med 126(5):618-620, 2002. e-Pub 2002. PMID: 11958674.
60. Resetkova E, Hoda SA. Images in pathology. Mammary crystalloids. Int J Surg Pathol 10(2):148, 2002. e-Pub 2002. PMID: 12075409.
61. Resetkova E, Padula A, Hoda SA. Pathologic quiz case. A pelvic mass with abdominal dissemination. Arch Pathol Lab Med 125(5):703-704, 2001. e-Pub 2001. PMID: 11300953.
62. Kawai K, Resetkova E, Enomoto T, Fornasier V, Volpé R. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice. J Clin Endocrinol Metab 83(1):157-164, 1998. e-Pub 1998. PMID: 9435434.
63. Togun RA, Resetkova E, Kawai K, Enomoto T, Volpé R. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 82(3):243-249, 1997. e-Pub 1997. PMID: 9073547.
64. Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Proc Assoc Am Physicians 109(2):126-135, 1997. e-Pub 1997. PMID: 9069581.
65. Mukuta T, Arreaza G, Nishikawa M, Resetkova E, Jamieson C, Tamai H, Volpé R. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Clin Invest Med 20(1):5-15, 1997. e-Pub 1997. PMID: 9013039.
66. Mukuta T, Nishikawa M, Arreaza G, Resetkova E, Yoshikawa N, Fornasier V, Young E, Volpé R. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue. Thyroid 6(5):429-436, 1996. e-Pub 1996. PMID: 8936667.
67. Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpé R. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Thyroid 6(4):267-273, 1996. e-Pub 1996. PMID: 8875745.
68. Arreaza G, Yoshikawa N, Mukuta T, Resetkova E, Barsuk A, Nishikawa M, Muallim C, Miller N, Jamieson C, Volpe R. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. J Clin Endocrinol Metab 80(12):3724-3731, 1995. e-Pub 1995. PMID: 8530625.
69. Yoshikawa N, Morita T, Arreaza G, Resetkova E, Mukuta T, Volpe R. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease. Clin Invest Med 18(2):91-98, 1995. e-Pub 1995. PMID: 7788961.
70. Resetkova E, Nishikawa M, Mukuta T, Arreaza G, Fornasier VL, Volpe R. Homing of 51Cr-labeled human peripheral lymphocytes to Graves' thyroid tissue xenografted into SCID mice. Thyroid 5(4):293-298, 1995. e-Pub 1995. PMID: 7488871.
71. Nishikawa M, Mukuta T, Arreaza G, Resetkova E, Poppema S, Tamai H, Volpe R, Lazarovits AI. Effects of monoclonal antibody against CD45RB on peripheral blood mononuclear cell proliferation and on HLA-DR and adhesion molecule expression on thyrocytes of patients with autoimmune thyroid disease. Thyroid 5(4):265-272, 1995. e-Pub 1995. PMID: 7488866.
72. Mukuta T, Yoshikawa N, Arreaza G, Resetkova E, Leushner J, Song YH, Akasu F, Onaya T, Volpe R. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes. J Clin Endocrinol Metab 80(4):1264-1272, 1995. e-Pub 1995. PMID: 7714099.
73. Yoshikawa N, Arreaza G, Morita T, Mukuta T, Resetkova E, Miller N, Volpe R. Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease. Horm Metab Res 26(9):419-423, 1994. e-Pub 1994. PMID: 7835825.
74. Yoshikawa N, Arreaza G, Mukuta T, Resetkova E, Miller N, Jamieson C, Nishikawa M, Inada M, Volpe R. Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice. Clin Endocrinol (Oxf) 41(1):31-39, 1994. e-Pub 1994. PMID: 7519528.
75. Yoshikawa N, Arreaza G, Morita T, Mukuta T, Resetkova E, Akasu F, Miller N, Jamieson C, Volpe R. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. J Clin Endocrinol Metab 78(2):367-374, 1994. e-Pub 1994. PMID: 8106624.
76. Yoshikawa N, Arreaza G, Mukuta T, Resetkova E, Miller N, Jamieson C, Volpe R. Studies of human thyroid xenografts from Hashimoto's thyroiditis in severe combined immunodeficient (SCID) mice: detection of thyroid stimulation-blocking antibody. Thyroid 4(1):13-18, 1994. e-Pub 1994. PMID: 7914445.
77. Morita T, Yoshikawa N, Akasu F, Asa S, Miller N, Resetkova E, Arreaza G, Mukuta T, Jamieson C, Volpé R. Thyroid lymphomas in human thyroid tissue with autoimmune thyroid disease xenografted in severe combined immunodeficient (SCID) mice. Endocr Pathol 5:169-177, 1994. e-Pub 1994.
78. Resetkova E, Notenboom R, Arreaza G, Mukuta T, Yoshikawa N, Volpe R. Seroreactivity to bacterial antigens is not a unique phenomenon in patients with autoimmune thyroid diseases in Canada. Thyroid 4(3):269-274, 1994. e-Pub 1994. PMID: 7833662.
79. Yoshikawa N, Morita T, Resetkova E, Arreaza G, Carayon P, Volpe R. Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease. J Endocrinol Invest 16(8):609-617, 1993. e-Pub 1993. PMID: 8258649.
80. Resetkova E, Morita T, Akasu F, Carayon P, Volpe R. In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Clin Invest Med 16(4):256-264, 1993. e-Pub 1993. PMID: 8306534.
81. Morita T, Yoshikawa N, Akasu F, Resetkova E, Arreaza G, Miller N, Jamieson C, Volpe R. Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab 77(1):254-262, 1993. e-Pub 1993. PMID: 8100830.
82. Resetkova E, Arreaza G, Yoshikawa N, Morita T, Kim H, Carayon P, Volpe R. Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD). Clin Exp Immunol 91(3):397-403, 1993. e-Pub 1993. PMID: 8443962.
83. Akasu F, Morita T, Resetkova E, Miller N, Akasu R, Jamieson C, Volpe R. Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 76(1):223-230, 1993. e-Pub 1993. PMID: 7678424.
84. Akasu F, Morita T, Resetkova E, Yoshikawa N, Carayon P, Volpe R. Sensitization of T lymphocytes to thyroglobulin and thyroperoxidase in autoimmune thyroid diseases. Autoimmunity 14(4):261-268, 1993. e-Pub 1993. PMID: 8102254.
85. Resetkova E, Morita T, Akasu F, Carayon P, Volpe R. Effect of human thyroglobulin on the production of platelet activating factor from peripheral blood mononuclear cells from patients with autoimmune thyroid diseases. Reg Immunol 4(4):204-208, 1992. e-Pub 1992. PMID: 1476872.
86. Strbak V, Giraud P, Resetkova E, Ouafik LH, Dutour A, Oliver C, Povazanova K, Randuskova A. Thyroliberin (TRH) and TRH free acid (TRH-OH) present in milk do not originate from local synthesis in mammary gland. Endocr Regul 25(1-2):134-138, 1991. e-Pub 1991. PMID: 1958827.
87. Resetkova E, Strbak V, Hnilica P. Incidence of thyroid hormone autoantibodies in patients with thyroid diseases with respect to diagnosis, other types of autoantibodies, duration of disease and treatment. Endocrinol Exp 23(2):105-116, 1989. e-Pub 1989. PMID: 2776694.
88. Resetkova E, Strbak V, Hnilica P, Zorad S. [Comparison of the results of radioimmunologic and hemagglutination methods in the determination of antibodies against thyroglobulin and the effect of these antibodies on thyroglobulin serum levels]. Bratisl Lek Listy 90(4):263-267, 1989. e-Pub 1989. PMID: 2765955.
89. Strbak V, Ouafik LH, Resetkova E, Oliver C, Giraud P, Dutour A, Salers P, Randuskova A. Thyrotropin releasing hormone in the pancreas of newborn rats from streptozotocin-treated mothers. Life Sci 44(12):779-787, 1989. e-Pub 1989. PMID: 2495394.
90. Strbak V, Huttova M, Kubasakova S, Resetkova E, Randuskova A, Predna E. Exchange transfusion in premature newborns: effect of maturity on thyrotropin and thyroxine responses. Endocrinol Exp 21(4):269-273, 1987. e-Pub 1987. PMID: 3501980.
91. Strbak V, Skultetyova M, Michalickova J, Randuskova A, Macho L, Pohlova G, Resetkova E. Effect of breast-feeding on infant thyroid activity: 3 year follow up-longitudinal study. Endocrinol Exp 20(2-3):257-266, 1986. e-Pub 1986. PMID: 3489599.
92. Kerollos Nashat Wanis MD, PhD, Rrita Krasniqi DO, Susie X Sun MD, Erika Resetkova MD, PhD, Rosa F Hwang MD, Kelly K Hunt MD, Rosalind P Candelaria MD, Lei Huo MD, PhD, Puneet Singh MD,MS. Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis following Neoadjuvant Therapy in Patients with Clinically Node-Negative, Hormone Receptor-Positive, HER2-Negative Breast Cancer. Annals of Surgical Oncology.

Invited Articles

1. Resetkova E. Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis. Semin Oncol 35(1):25-32, 2008. e-Pub 2008. PMID: 18308143.

Review Articles

1. Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez-Angulo AM, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109(3):417-426, 2008. e-Pub 2008. PMID: 17653852.
2. Hoda SA, Chiu A, Resetkova E, Harigopal M, Hoda RS, Osborne MP. Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions. Microsc Res Tech 59(2):85-91, 2002. e-Pub 2002. PMID: 12373718.
3. Volpe R, Akasu F, Morita T, Yoshikawa N, Resetkova E, Arreaza G, Mukuta T. New animal models for human autoimmune thyroid disease. Xenografts of human thyroid tissue in severe combined immunodeficient (SCID) and nude mice. Horm Metab Res 25(12):623-627, 1993. e-Pub 1993. PMID: 8119666.
4. Volpe R, Kasuga Y, Akasu F, Morita T, Yoshikawa N, Resetkova E, Arreaza G. The use of the severe combined immunodeficient mouse and the athymic "nude" mouse as models for the study of human autoimmune thyroid disease. Clin Immunol Immunopathol 67(2):93-99, 1993. e-Pub 1993. PMID: 8519094.

Other Articles

1. Ijaz K, Yang WT, Resetkova E Mammary Duct Ectasia Presenting As MRI Non-mass Enhancement in a RAD51C Carrier With Pituitary Adenoma. PMID: 42137657.

Abstracts

1. Jennifer H Chen MD, Kerollos Nashat Wanis MD, PhD, Rahman M, Gianchandani A, Isabelle Bedrosian MD, Nina Tamirisa MD, Min Yi MD, PhD, Akshara Raghavendra MD, MS, Puneet Singh MD, MS, Mediget Teshome MD, MPH, Susie Sun MD, MS, Henry Kuerer MD, PhD, Kelly K Hunt MD, Funda Meric-Bernstam MD, Taiwo Adesoye MD, MPH. ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node.Negative HR+/ HER2. Breast Cancer Undergoing Mastectomy. e-Pub 2026.
2. Sun H, Huo L, Sweeney K, Resetkova E, Chai D, Chen H, Albarracin C, Wu Y, Ding Q. SMARCA4/BRG1 Deficiency in Breast Carcinoma by Immunohistochemistry Study. Mod Pathol 104(3):S274-75, 2024. e-Pub 2024.
3. Ye Q, Klippel D, Albarracin C, Chen H, Contreras A, Ding Q, Huo L, Khazai L, Middleton L, Resetkova E, Sahin A, Sun H, Sweeney K, Symmans W, Wu Y, Krishnamurthy S. A Prospective Study of Real Time Whole Slide Imaging of Frozen Sections for Intraoperative Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer. Mod Pathol 104(3):S321-22, 2024. e-Pub 2024.
4. Yoon E, Wang G, Wu Y, Chen H, Albarracin C, Resetkova E, Krishnamurthy S, Salisbury T, Sahin A, Ding Q. Expression of TRPS1, SOX10 and GATA3 in Triple Negative Invasive Ductal and Lobular Carcinomas. USCAP 111th Annual Meeting 2022, 2022. e-Pub 2022.
5. Van Bokstal MR, Dano H, Altinay S, Arnould L, Bletard N, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambien K, MacGrogan GM, Marchio C, Martinez D, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout A, Schelfhout V, Shaaban AM, Sinke R, Stanciu-Pop CM, Stobbe C, Van Deurzen CHM, Van de Vijver K Van Rompuy A, Verschuere S, Vincent-Salomon A, Wen H, Bouzin C, Galant C. Upfront dichotomous assessment of ductal carcinoma in situ of the breast to reduce inter-observer variability: the DCISion study. San Antonio Breast cancer Symposium, 2019. e-Pub 2019.
6. Resetkova E. Breast implant capsule-associated pathology:from " common" to "rare "to "unique". 30th European Congress of Pathology, Bilbao, Spain, 2018. e-Pub 2018.
7. Resetkova E. Breast Implant Capsule-Associated Pathology: From "Common" to "Rare" to "Unique" - 35th Annual Miami Breast Conference. Miami, FL, 2018. e-Pub 2018.
8. Li Y, Luthra R, Hu J, Shen L, Broadus RR, Resetkova E, Wu Y, Albarracin CT. Mir-182*, mir-183, and mir-143 are deregulated in endometrial endometroid cancers. Mod Pathol 30(S2):459A, 2017. e-Pub 2017.
9. Albarracin C, Dhamne S, Arun B, Ward K, Wu Y, Rosen D, Cui X, Resetkova E, Duan X, Chen H, Bedrosian I, Barrera A. BRCA1 and BRCA2-Associated Breast Cancers Demonstrate Distinct Histopathologic Features, Biomarker Expression Patterns and Molecular Subtypes. Mod Pathol 29(2):39A, 2016. e-Pub 2016.
10. Stolnicu S, Moncea D, Dema A, Buiga R, Moldovan C, Georgescu R, Toganel C, Voidazan S, Resetkova E, Comanescu M, Alvarado-Cabrero I. Analysis of Clinical-Pathological Data with Impact on Overall Survival (OS) in Male Breast Carcinoma: An International Multi-Institutional Study of 220 Cases. Mod Pathol 29(2):74A, 2016. e-Pub 2016.
11. Stolnicu S, Moncea D, Dema A, Geambasu S, Moldovan M, Comanescu S, Voidizan R, Georgescu R, Alvarado-Cabrero I, Resetkova E, Buiga R. Androgen receptor (AR) expression in invasive male breast carcinoma (MBC): An international multi-institutional review of 168 cases. Virchows Arch 469(Suppl 1):S46, PS-01-004, 2016. e-Pub 2016.
12. Resetkova E, Padula, A. IgG4-Related Sclerosing Mastitis(IgG4-RSM) of the Breast. Diagnostic Conundrum on Core Needle Biopsy (CB) Specimens. Virch Arch, 2014. e-Pub 2014.
13. Resetkova E, Padula A. IgG4-related sclerosing mastitis(IgG4-RSM) of the breast: An uncommon entity and diagnostic challenge on core biopsy (CB). Mod Pathol 27(2):77A, 2014. e-Pub 2014.
14. Dhamne S, Sneige N, Rosen D, Bedrosian I, Resetkova E, Wu Y, Arun B, Albarracin C. High nuclear expression of p27 correlates with luminal A molecular subtype of ductal carcinoma in situ of breast. Mod Pathology 27(2):45A, 2014. e-Pub 2014.
15. Duan X, Gullet A, Sneige N, Rosen D, Resetkova E, Ersahin C, Wu Y, Bedrosian I, Albarracin CT. Clinicopathologic features of male paget disease of breast: 11 cases from a single institution. Mod Pathol 26(Suppl 2):37A, 2013. e-Pub 2013.
16. Duan X, Gullet A, Sneige N, Resetkova E, Ersahin C, Wu Y, Bedrosian I, Albarracin C. Male mammary Paget disease: Ten cases from a single institute. Virch Arch 463(Suppl:PS-17-090), 2013. e-Pub 2013.
17. Resetkova E. Utility of immunoperoxidase studies in improving diagnosis of metastases in body cavity effusions. Acta Cytologica 57(Suppl 1):1-172, 102P, 2013. e-Pub 2013.
18. Resetkova E, Sneige N. Proposal for a new classification of "equivocal" fibroepithelial lesions (FELs). Mod Pathol 26((Suppl 2)):482A, 2013. e-Pub 2013.
19. Aquil B, Arun B, Sneige N, Barrera-Gutierez AM, Rosen D, Abrahams S, Resetkova E, Wu Y, Albarracin CT. Histology of breast cancer in patients with Lynch syndrome. Mod Pathol 26(Suppl 2):27A, 2013. e-Pub 2013.
20. Gullett AE, Prieto VG, Lopez K, Arun B, Bedrosian I, Resetkova E, Wu Y, Albarracin CT. Type of mammary Paget disease is associated with disease free survival. Mod Pathol 23(Suppl 1):115A, 2012. e-Pub 2012.
21. Gullett AE, Sneige N, Prieto VG, Kelly CM, Bassett RL, Resetkova E, Duan, X, Li Y, Rosen D, Wu Y, Huo L, Klein K, Bedrosian I, Arun B, Hunt K, Albarracin CT. Pathological and clinical characteristics of mammary Paget disease: 25-year experience from a major tertiary referral center. Mod Pathol 25(Suppl 2):121A, 2012. e-Pub 2012.
22. Albarracin CT, Gullet A, Prieto V, Kelly C, Duan X, Bassett R, Klein K, Resetkova E, Rosen DG, Wu Y, Sneige N. Histopathologic charateristics and disease-free survival of mammary Paget disease?. Virchows Arch 459((Suppl):S3), 2011. e-Pub 2011.
23. Duan X, Sneige NE, Gullett AE, Prieto VG, Resetkova E, Albarracin CT. Minimally invasive Paget disease of breast: An under-recognized entity in the breast. Mod Pathol 24(Suppl 1):146, 2011. e-Pub 2011.
24. Adrada B, Lane D, Arribas EM, Resetkova E, Huo L, Yang WT. The significance of residual mammographic calcifications after neoadjuvant therapy (Scientific Presentation). Radiological Society of North America (RSNA), 2010. e-Pub 2010.
25. Resetkova E, Albarracin C, Arribas E, Sneige N. Careful initial clinical-radiologic-pathologic correlation should dictate clinical management of equivocal fibroepithelial lesions diagnosed on core biopsy. Vichows Arch 457(OP002):149, 2010. e-Pub 2010.
26. Chang KN, E R, Huo L, Yang, WT. Imaging-pathologic correlation in fat necrosis of the breast (Education Exhibit). Radiological Society of Noth American (RSNA), 2010. e-Pub 2010.
27. Wei B, Tian F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton LP, Sahin A, Chen J, Abraham SC, Wu, Y. Prognostic factors of primary invasive mammary neuroendocrine carcinoma: clinicopathologic analysis of 74 cases. Mod Pathol 23(Suppl 1):77A, 2010. e-Pub 2010.
28. Resetkova E, Khazai L, Arribas E. Diagnosis of cellular fibroepithelial lesion of the breast by core biopsy: Guide to management based on clinical, radiologic, and pathologic correlation 6-year experience at a single institution. Breast Cancer Symposium Proceedings. Breast Cancer Symposium, San Francisco, California(Abstract 121), 2009. e-Pub 2009.
29. Gullett AE, Duan X, Fuller GN, Brown R, Li Y, Luthra R, Wiseman W, Resetkova E, Yao H, Puduvali V, Wu Y, Bruner JM, Albarracin CT. Expression of annexin A1 and constitutive activation of the Akt/mTOR pathway in high-grade diffuse gliomas: a potential connection with S phase kinase-associated protein (Skp2) in glioma progression. Mod Pathol 22(Suppl 1):1492A, 2009. e-Pub 2009.
30. Ngyuen CV, Resetkova E, Huo L. Mucocele-like lesions of breast with no or minimal epithelial atypia on core biopsy: to excise or not?. Mod Pathol 22(Suppl 1):258A, 2009. e-Pub 2009.
31. Albarracin CT, Siguake E, Whitman G, Yang WT, Resetkova E, Johnson MM, Ngyuen CV, Sneige N. Atypical and columnar cell lesions in breast needle biopsies for indeterminate microcalcifications: predictors of higher risk findings requiring surgical excision. 31st Annual San Antonio Breast Cancer Symposium,(Abs. 3004), 2008. e-Pub 2008.
32. Tang F, Gilcrease M, Albarracin CT, Huo L, Middleton LP, Resetkova E, Wu Y. Invasive solid papillary carcinoma of the breast: A clinicopathologic analysis of 52 cases. Mod Pathol 21(Suppl 1, Abs. 2481), 2008. e-Pub 2008.
33. Resetkova E, Thorat M, Badve S. Expression of ALDH1 (putative cancer stem cell marker) does not correlate with response to neoadjuvant chemotherapy (NATC) in breast carcinoma. Histopathology 53(Suppl. 1):134, 2008. e-Pub 2008.
34. Resetkova E, Edelweiss M, Albarracin C, Yang W. Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum assisted core biopsy: when excision is necessary?. Histopathology 53(Suppl. 1):133, 2008. e-Pub 2008.
35. Albarracin C, Ricketts R, Willer S, Li Y, Huo L, Wu Y, Resetkova E. Differential expression of cytokeratins 903 and 5/6 antibodies in breast cancer tissue compared to adjacent benign epithelium. Histopathology 53(Suppl. 1):053, 2008. e-Pub 2008.
36. Ferreira M, Gupta N, Resetkova E. Pseudoangiomatous stromal hyperplasia (PASH) tumors on core needle biopsy: is excision necessary?. Virchows Arch 451:OP9-6, 2007. e-Pub 2007.
37. Uzquiano MC, Resetkova E, Arribas E, Sahin A. Mitotic index evaluated with phosphohistone H3 as predictor of outcome on surgical excision in challenging fibroepithelial lesions. USCAP, San Diego, California, 2007. e-Pub 2007.
38. Rickets RS, Otis CN, Resetkova E, Sneige N. Prognostic markers in estrogen, progesterone and Her-2/neu negative invasive breast carcinomas. USCAP, San Diego, California, 2007. e-Pub 2007.
39. Yang WT, Le-Petross HT, Macapinlac H, Gonzalez-Angulo AM, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M. Functional (PET/CT) compared to conventional (mammography [M], sonography [US], MRI) imaging: Defining novel assessment modalities for inflammatory breast cancer (IBC). ASCO Annual Meeting, June 1-5, Chicago, Illinois, 2007. e-Pub 2007.
40. Dawood S, Gonzalez-Angulo AM, Broglio K, Gong Y, Resetkova E, Yang WT, Barnett CM, Islam R, Ueno NT, Hortobagyi GN, Cristofanilli M. HER-2 positive inflammatory breast cancer: high pathologic response rate with transtuzumab-based neodjuvant therapy. 30th Annual San Antonio Breast Cancer Symposium, December 13-16,(Abs. 4060), 2007. e-Pub 2007.
41. Albarracin CT, Sigauke E, Yang W, Resetkova E, Selinko V, Whitman G, Sneige N. Columnar cell lesions with atypia: to excise or not to excise?. 29th Annual San Antonio Breast Cancer Symposium, December 14-17, 2006. e-Pub 2006.
42. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of Annexin A1 in esophageal and esophagogastric junction adenocarcinomas: Association with poor outcome. Clin Cancer Res 119(Suppl 1):47A, 2006. e-Pub 2006. PMID: 16899607.
43. Huo L, Resetkova E, Lopez A, Sneige N. Sentinel lymph node (SLN) sampling in patients with core biopsy diagnosis of ductal carcinoma in situ (DCIS): UT M. D. Anderson Cancer experience and future recommendations. 29th Annual San Antonio Breast Cancer Symposium, December 14-17, 19(Suppl 1):30A, 2006. e-Pub 2006.
44. Baruch AC, Sneige N, Cristofanilli M, Resetkova E. Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her-2/neu in triple negative breast carcinomas. Mod Pathol 19(Suppl 1):21A, 2006. e-Pub 2006.
45. Edelweiss M, Selinko V, Yang WT, Resetkova E. Eleven-Gauge Stereotactic Mammotome Needle Core Biopsy: A Novel Approach to Management of Radial Scars. Mod Pathol 18(Suppl 1):32A, 2005. e-Pub 2005.
46. Gonzalez-Angulo AM, Resetkova E, Sneige N, Buzdar AA, Kau SW, Yamamura Y, Hortobagyi GN, Cristofanilli M. Expression of p53, MDM-2 and Muc-1 predicts prognosis in inflammatory breast cancer (IBC). . 15th International Congress of Anti-Cancer Treatment, Palais des Congress in Paris, 2004. e-Pub 2004.
47. Resetkova E, Albarracin CT, Sneige N. Collagenous spherulosis of the breast: morphologic study of 36 cases. Mod Pathol 17(Suppl 1):47A, 2004. e-Pub 2004.
48. Resetkova E Sneige N. Predictors of subsequent invasion and sentinel lymph node metastases in patients with ductal carcinoma in situ diagnosed upon core needle biopsy. Mod Pathol 17(Suppl 1):47A, 2004. e-Pub 2004.
49. Gokhale S, Sneige N, Diaz LK, Rosen D, Resetkova E, Sahin A, Albarracin CT. Assessment of two automated systems of imaging technology in evaluation of estrogen receptor status in invasive carcinoma of breast. Mod Pathol 17(Suppl 1):32A, 2004. e-Pub 2004.
50. Resetkova E, Fornage B, Singletary E, Mirza AN, Ross M, Sneige N. Radiofrequency ablation in early breast cancer: qualitative and quantitative pathologic evaluation. Mod Pathol 16(1):45A, 2003. e-Pub 2003.
51. Yao DX, Hoda SA, Kuhel W, Yin D, Harigopal M, Resetkova E, DeLellis RA. Are touch-imprints reliable for intra-operative identification of parathyroid?. Mod Pathol 15:122A, 2002. e-Pub 2002.
52. Resetkova E, Swistel A, Hoda SA. Cytokeratin-positive isolated single cells in sentinel lymph node: Metastases or traumatic dispersal. Amer J Clin Pathol 118(4):650, 2002. e-Pub 2002.
53. Resetkova E, Hoda SA, DeLellis RA. Are isolated single cytokeratin positive cells in sentinel lymph nodes biologically significant. Mod Pathol 15:49A, 2002. e-Pub 2002.

Book Chapters

1. Karakas C, Resetkova E, Sahin A. In: Practical Surgical Pathology of the Breast. Juan P Pallazzo, 2018.
2. Hoda SA, Resetkova E. Pathologic Examinations of Breast and Lymph Node Specimens, Including Sentinel Lymph Nodes. In: Chapter 44. In: Rosen's Breast Pathology. 4th Edition. Lippincott Williams & Wilkins, 1263-1336, 2014.
3. Karakas C, Resetkova E, Sahin A. Papillary Lesions of the Breast. In: Difficult Diagnoses in Breast Pathology. Juan P Pallazo, 2011.
4. Hnilica P, Durechova E, Podoba J, Resetkova E. Occurence of diffuse lymphoid thyroiditis (DLT) in goitres during long term iodine prophylaxis in our area. In: Endokrinologie interdisciplinar. Wissenschaftliche Beitrage, 39-44, 1998.
5. Volpé R, Akasu F, Kasuga Y, Morita T, Yoshikawa N, Resetkova E, Arreaza G, Mukuta T. The use of athymic "nude" mouse and severe immunodeficient mouse as models for the study of autoimmune thyroid disease. In: 80 years of Hashimoto disease. Excerpta Medica, 81-89, 1993.
6. Morita T, Yoshikawa N, Akasu F, Resetkova E, Arreaza G, Volpé R. Thyroid stimulating antibodies in severe combined immunodeficient mice xenotransplanted with Graves' disease thyroid tissue. . In: 80 years of Hashimoto disease. Excerpta Medica, 687-691, 1993.
7. Yoshikawa N, Morita T, Resetkova E, Arreaza G, Akasu F, Volpé R. Inadequate activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease. In: 80 years of Hashimoto disease. Excerpta Medica, 331-335, 1993.
8. Strbak V, Boudouresque F, Jurcovicova J, Resetkova E, Oliver C, Guillaume V, Vigas M. Maturation of neuroendocrine regulation of some pituitary hormones. In: Ontogenesis and genetic-evolutionary aspects of neuroendocrine regulation of stress. In: Novosibirsk. Nauka, 17-29, 1990.

Books (edited and written)

1. Contributor. Practical Surgical Pathology of Breast. Juan P Pallazzo, 2018.
2. Contributor. Rosen's Breast Pathology. Ed(s) 4th Edition. Lippincott Williams & Wilkins, 2014.
3. Pallazo JP. Difficult diagnosis in Breast Pathology. Ed(s) 1st Edition, 2011.

Letters to the Editor

1. Stolnicu S, Moldovan C, Resetkova E. Even small pure tubular carcinoma of the breast (stage T1a and T1b) can be associated with lymph node metastases - The U T MD Anderson Cancer Center experience. Eur J Surg Oncol 42: 911-2, 2016.
2. Albarracin C, Edgerton ME, Gilcrease MZ, Huo L, Krishnamurthy S, Middleton LP, Resetkova E, Sahin AA, Sneige N, Fraser WS, Wu Y. Is it too soon to start reporting HER2 genetic heterogeneity?. Arch Pathol Lab Med 134: 162-3; author reply 163, 2010.